CYB561A3
Lysosomal membrane ascorbate-dependent ferrireductase CYB561A3
Also known as: CYAC3_HUMAN, CYBASC3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBI2
- Gene
- CYB561A3
- Ensembl
- ENSG00000162144
- Chromosome
- 11
- Canonical length
- 242 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable transmembrane ascorbate ferrireductase activity. Predicted to be involved in intracellular iron ion homeostasis. Located in nucleolus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
242 residues, UniProt reviewed canonical sequence.
>Q8NBI2|CYB561A3
1 MVSGRFYLSC LLLGSLGSMC ILFTIYWMQY WRGGFAWNGS IYMFNWHPVL MVAGMVVFYG
61 GASLVYRLPQ SWVGPKLPWK LLHAALHLMA FVLTVVGLVA VFTFHNHGRT ANLYSLHSWL
121 GITTVFLFAC QWFLGFAVFL LPWASMWLRS LLKPIHVFFG AAILSLSIAS VISGINEKLF
181 FSLKNTTRPY HSLPSEAVFA NSTGMLVVAF GLLVLYILLA SSWKRPEPGI LTDRQPLLHD
241 GELocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYB561A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 292 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 292 nTPM
- skin: 72 nTPM
- tonsil: 66 nTPM
- lymph node: 66 nTPM
- spleen: 47 nTPM
- liver: 32 nTPM
Single-cell type
- melanocytes: 530 nCPM
- pdcs: 295 nCPM
- adrenal cortex cells: 166 nCPM
- early spermatids: 73 nCPM
- cytotrophoblasts: 61 nCPM
- b-cells: 59 nCPM
Immune cell
- plasmacytoid DC: 844 nTPM
- naive B-cell: 388 nTPM
- memory B-cell: 315 nTPM
- total PBMC: 85 nTPM
- classical monocyte: 66 nTPM
- non-classical monocyte: 64 nTPM
Brain region
- choroid plexus: 38 nTPM
- midbrain: 30 nTPM
- white matter: 29 nTPM
- medulla oblongata: 28 nTPM
- pons: 27 nTPM
- spinal cord: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYB561A3 as an antibody target. Whether an autoantibody or antibody against CYB561A3 could matter depends on whether native CYB561A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYB561A3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYB561A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...